Diversity of human skeletal muscle in health and disease: Contribution of proteomics

Journal of Proteomics

Volumn 74, Issue 6, 2011, Pages 774-795

  Gelfi, Cecilia ^a,b   Vasso, Michele ^a,b   Cerretelli, Paolo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

DIGE; Mass spectrometry; Muscle; Proteomics

Indexed keywords

AGRIN; DYSTROPHIN; FUKUTIN; INTEGRIN; LAMININ ALPHA2; NEUREXIN; NITRIC OXIDE SYNTHASE; PROTEOME; SELENOPROTEIN;

AGING; ARM; COLD; DELTOID MUSCLE; DERMATOMYOSITIS; DYSFERLINOPATHY; ECCENTRIC MUSCLE CONTRACTION; EXERCISE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; HYPOXIA; IMMOBILIZATION; INCLUSION BODY MYOSITIS; INSULIN RESISTANCE; MASS SPECTROMETRY; METABOLISM; MYOSITIS; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

AGING; ANIMALS; ANOXIA; COLD TEMPERATURE; EXERCISE; HUMANS; IMMOBILIZATION; INSULIN RESISTANCE; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; MYOSITIS, INCLUSION BODY; NEUROMUSCULAR DISEASES; PHYSICAL CONDITIONING, ANIMAL; PROTEOME;

ANIMALIA;

EID: 79955477252     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.02.028     Document Type: Review

References (147)

1. Buller A.J., Eccles J.C., Eccles R.M. Interactions between motoneurones and muscles in respect of the characteristic speeds of their responses. J Physiol 1960, 150:417-439.
2. Pette D., Wimmer M., Nemeth P. Do enzyme activities vary along muscle fibres?. Histochemistry 1980, 67:225-231.
3. Pette D. Historical perspectives: plasticity of mammalian skeletal muscle. J Appl Physiol 2001, 90:1119-1124.
4. Haddad F., Qin A.X., Bodell P.W., Zhang L.Y., Guo H., Giger J.M., et al. Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload. Am J Physiol Heart Circ Physiol 2006, 290:H2351-H2361.
5. Weiss A., Schiaffino S., Leinwand L.A. Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity. J Mol Biol 1999, 290:61-75.
6. Staron R.S., Pette D. The multiplicity of combinations of myosin light chains and heavy chains in histochemically typed single fibres. Rabbit soleus muscle. Biochem J 1987, 243:687-693.
7. Pette D., Staron R.S. Mammalian skeletal muscle fiber type transitions. Int Rev Cytol 1997, 170:143-223.
8. Pette D., Staron R.S. Myosin isoforms, muscle fiber types, and transitions. Microsc Res Tech 2000, 50:500-509.
9. Stephenson G.M. Hybrid skeletal muscle fibres: a rare or common phenomenon?. Clin Exp Pharmacol Physiol 2001, 28:692-702.
10. Caiozzo V.J., Baker M.J., Huang K., Chou H., Wu Y.Z., Baldwin K.M. Single-fiber myosin heavy chain polymorphism: how many patterns and what proportions?. Am J Physiol Regul Integr Comp Physiol 2003, 285:R570-R580.
11. Stevens L., Bastide B., Mourier Y. Muscle plasticity and variations in myofibrillar protein composition of mammalian muscle fibers. Skeletal Muscle Plasticity in Health and Diseases: From Genes to Whole Muscle 2006, 213-264.
12. D'Antona G., Pellegrino M.A., Adami R., Rossi R., Carlizzi C.N., Canepari M., et al. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol 2003, 552:499-511.
13. Stevens L., Bastide B., Bozzo C., Mounier Y. Hybrid fibres under slow-to-fast transformations: expression is of myosin heavy and light chains in rat soleus muscle. Pflugers Arch 2004, 448:507-514.
14. Larsson L., Moss R.L. Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles. J Physiol 1993, 472:595-614.
15. Schiaffino S., Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996, 76:371-423.
16. Ebashi S.N. Proteins of the myofibril. The structure and function of muscle 1973.
17. Fitts R.H., Riley D.R., Widrick J.J. Physiology of a microgravity environment invited review: microgravity and skeletal muscle. J Appl Physiol 2000, 89:823-839.
18. Bamman M.M., Ragan R.C., Kim J.S., Cross J.M., Hill V.J., Tuggle S.C., et al. Myogenic protein expression before and after resistance loading in 26- and 64-yr-old men and women. J Appl Physiol 2004, 97:1329-1337.
19. Pette D., Staron R.S. Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 1990, 116:1-76.
20. Schiaffino S, Sandri M, Murgia M. Signaling pathway controlling muscle fiber size and type in response to nerve activity. In: Springer, editor. Skeletal Muscle Plasticity in Health and Diseases: From Genes to Whole Muscle 2006. p. 91-119.
21. Mammucari C., Schiaffino S., Sandri M. Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy 2008, 4:524-526.
22. Giometti C.S., Anderson N.G., Anderson N.L. Muscle protein analysis. I. High-resolution two-dimensional electrophoresis of skeletal muscle proteins for analysis of small biopsy samples. Clin Chem 1979, 25:1877-1884.
23. Giometti C.S., Barany M., Danon M.J., Anderson N.G. Muscle protein analysis. II. Two-dimensional electrophoresis of normal and diseased human skeletal muscle. Clin Chem 1980, 26:1152-1155.
24. Giometti C.S., Anderson N.G. Muscle protein analysis. III. Analysis of solubilized frozen-tissue sections by two-dimensional electrophoresis. Clin Chem 1981, 27:1918-1921.
25. Gelfi C., De Palma S., Cerretelli P., Begum S., Wait R. Two-dimensional protein map of human vastus lateralis muscle. Electrophoresis 2003, 24:286-295.
26. Yan J.X., Wait R., Berkelman T., Harry R.A., Westbrook J.A., Wheeler C.H., et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21:3666-3672.
27. Hu L., Ye M., Jiang X., Feng S., Zou H. Advances in hyphenated analytical techniques for shotgun proteome and peptidome analysis-a review. Anal Chim Acta 2007, 598:193-204.
28. Li X., Gong Y., Wang Y., Wu S., Cai Y., He P., et al. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics 2005, 5:3423-3441.
29. Hojlund K., Yi Z., Hwang H., Bowen B., Lefort N., Flynn C.R., et al. Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. Mol Cell Proteomics 2008, 7:257-267.
30. Yi Z., Bowen B.P., Hwang H., Jenkinson C.P., Coletta D.K., Lefort N., et al. Global relationship between the proteome and transcriptome of human skeletal muscle. J Proteome Res 2008, 7:3230-3241.
31. Celegato B., Capitanio D., Pescatori M., Romualdi C., Pacchioni B., Cagnin S., et al. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 2006, 6:5303-5321.
32. Parker K.C., Walsh R.J., Salajegheh M., Amato A.A., Krastins B., Sarracino D.A., et al. Characterization of human skeletal muscle biopsy samples using shotgun proteomics. J Proteome Res 2009, 8:3265-3277.
33. Schiaffino S., Sandri M., Murgia M. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 2007, 22:269-278.
34. Guttridge D.C. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care 2004, 7:443-450.
35. Frank D., Kuhn C., Katus H.A., Frey N. The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med 2006, 84:446-468.
36. Hojlund K., Bowen B.P., Hwang H., Flynn C.R., Madireddy L., Geetha T., et al. In vivo phosphoproteome of human skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS. J Proteome Res 2009, 8:4954-4965.
37. Lefort N., Yi Z., Bowen B., Glancy B., De Filippis E.A., Mapes R., et al. Proteome profile of functional mitochondria from human skeletal muscle using one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. J Proteomics 2009, 72:1046-1060.
38. Zhao X., Leon I.R., Bak S., Mogensen M., Wrzesinski K., Hojlund K., et al. Phosphoproteome analysis of functional mitochondria isolated from resting human muscle reveals extensive phosphorylation of inner membrane protein complexes and enzymes. Mol Cell Proteomics 2010, (Electronic publication ahead of print).
39. Unlu M., Morgan M.E., Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18:2071-2077.
40. Tonge R., Shaw J., Middleton B., Rowlinson R., Rayner S., Young J., et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1:377-396.
41. Capitanio D., Vigano A., Ricci E., Cerretelli P., Wait R., Gelfi C. Comparison of protein expression in human deltoideus and vastus lateralis muscles using two-dimensional gel electrophoresis. Proteomics 2005, 5:2577-2586.
42. Gelfi C., De Palma S., Ripamonti M., Eberini I., Wait R., Bajracharya A., et al. New aspects of altitude adaptation in Tibetans: a proteomic approach. FASEB J 2004, 18:612-614.
43. Gelfi C., Vigano A., Ripamonti M., Pontoglio A., Begum S., Pellegrino M.A., et al. The human muscle proteome in aging. J Proteome Res 2006, 5:1344-1353.
44. Hittel D.S., Hathout Y., Hoffman E.P., Houmard J.A. Proteome analysis of skeletal muscle from obese and morbidly obese women. Diabetes 2005, 54:1283-1288.
45. Hojlund K., Wrzesinski K., Larsen P.M., Fey S.J., Roepstorff P., Handberg A., et al. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 2003, 278:10436-10442.
46. Vigano A., Ripamonti M., De Palma S., Capitanio D., Vasso M., Wait R., et al. Proteins modulation in human skeletal muscle in the early phase of adaptation to hypobaric hypoxia. Proteomics 2008, 8:4668-4679.
47. De Palma S., Ripamonti M., Vigano A., Moriggi M., Capitanio D., Samaja M., et al. Metabolic modulation induced by chronic hypoxia in rats using a comparative proteomic analysis of skeletal muscle tissue. J Proteome Res 2007, 6:1974-1984.
48. Bosworth CAt, Chou C.W., Cole R.B., Rees B.B. Protein expression patterns in zebrafish skeletal muscle: initial characterization and the effects of hypoxic exposure. Proteomics 2005, 5:1362-1371.
49. Vogtel M., Michels A. Role of intermittent hypoxia in the treatment of bronchial asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol 2010, 10:206-213.
50. Johnson M.A., Polgar J., Weightman D., Appleton D. Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci 1973, 18:111-129.
51. Rosler K., Hoppeler H., Conley K.E., Claassen H., Gehr P., Howald H. Transfer effects in endurance exercise. Adaptations in trained and untrained muscles. Eur J Appl Physiol Occup Physiol 1985, 54:355-362.
52. Caiozzo V.J., Haddad F., Baker M.J., Herrick R.E., Prietto N., Baldwin K.M. Microgravity-induced transformations of myosin isoforms and contractile properties of skeletal muscle. J Appl Physiol 1996, 81:123-132.
53. Gelfi C., Vigano A., De Palma S., Ripamonti M., Begum S., Cerretelli P., et al. 2-D protein maps of rat gastrocnemius and soleus muscles: a tool for muscle plasticity assessment. Proteomics 2006, 6:321-340.
54. Simonsen L., Bulow J., Madsen J., Christensen N.J. Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue. Am J Physiol 1992, 263:E850-E855.
55. Astrup A., Bulow J., Madsen J., Christensen N.J. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol 1985, 248:E507-E515.
56. Wijers S.L., Schrauwen P., Saris W.H., van Marken Lichtenbelt W.D. Human skeletal muscle mitochondrial uncoupling is associated with cold induced adaptive thermogenesis. PLoS ONE 2008, 3:e1777.
57. Wijers S.L., Smit E., Saris W.H., Mariman E.C., van Marken Lichtenbelt W.D. Cold- and overfeeding-induced changes in the human skeletal muscle proteome. J Proteome Res 2010, 9:2226-2235.
58. Christiansen E., Garby L. Prediction of body weight changes caused by changes in energy balance. Eur J Clin Invest 2002, 32:826-830.
59. Holloway K.V., O'Gorman M., Woods P., Morton J.P., Evans L., Cable N.T., et al. Proteomic investigation of changes in human vastus lateralis muscle in response to interval-exercise training. Proteomics 2009, 9:5155-5174.
60. Burgomaster K.A., Howarth K.R., Phillips S.M., Rakobowchuk M., Macdonald M.J., McGee S.L., et al. Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol 2008, 586:151-160.
61. Burniston J.G. Changes in the rat skeletal muscle proteome induced by moderate-intensity endurance exercise. Biochim Biophys Acta 2008, 1784:1077-1086.
62. Takahashi M., Kubota S. Exercise-related novel gene is involved in myoblast differentiation. Biomed Res 2005, 26:79-85.
63. Guelfi K.J., Casey T.M., Giles J.J., Fournier P.A., Arthur P.G. A proteomic analysis of the acute effects of high-intensity exercise on skeletal muscle proteins in fasted rats. Clin Exp Pharmacol Physiol 2006, 33:952-957.
64. Gandra P.G., Valente R.H., Perales J., Pacheco A.G., Macedo D.V. Proteomic analysis of rat skeletal muscle submitted to one bout of incremental exercise. Scand J Med Sci Sports 2010, (Electronic publication ahead of print).
65. Yamaguchi W., Fujimoto E., Higuchi M., Tabata I. A DIGE proteomic analysis for high-intensity exercise-trained rat skeletal muscle. J Biochem 2010, 148:327-333.
66. Donoghue P., Doran P., Wynne K., Pedersen K., Dunn M.J., Ohlendieck K. Proteomic profiling of chronic low-frequency stimulated fast muscle. Proteomics 2007, 7:3417-3430.
67. Janssen I., Heymsfield S.B., Wang Z.M., Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88yr. J Appl Physiol 2000, 89:81-88.
68. Kent-Braun J.A., Ng A.V. Specific strength and voluntary muscle activation in young and elderly women and men. J Appl Physiol 1999, 87:22-29.
69. Narici M.V., Reeves N.D., Morse C.I., Maganaris C.N. Muscular adaptations to resistance exercise in the elderly. J Musculoskelet Neuronal Interact 2004, 4:161-164.
70. Larsson L., Li X., Frontera W.R. Effects of aging on shortening velocity and myosin isoform composition in single human skeletal muscle cells. Am J Physiol 1997, 272:C638-C649.
71. Trappe S., Gallagher P., Harber M., Carrithers J., Fluckey J., Trappe T. Single muscle fibre contractile properties in young and old men and women. J Physiol 2003, 552:47-58.
72. Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci 1995, 50. Spec No:11-6.
73. Aoyagi Y., Shephard R.J. Aging and muscle function. Sports Med 1992, 14:376-396.
74. Coggan A.R., Spina R.J., Rogers M.A., King D.S., Brown M., Nemeth P.M., et al. Histochemical and enzymatic characteristics of skeletal muscle in master athletes. J Appl Physiol 1990, 68:1896-1901.
75. Frontera W.R., Hughes V.A., Fielding R.A., Fiatarone M.A., Evans W.J., Roubenoff R. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol 2000, 88:1321-1326.
76. Marx J.O., Kraemer W.J., Nindl B.C., Larsson L. Effects of aging on human skeletal muscle myosin heavy-chain mRNA content and protein isoform expression. J Gerontol A Biol Sci Med Sci 2002, 57:B232-B238.
77. Balagopal P., Schimke J.C., Ades P., Adey D., Nair K.S. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab 2001, 280:E203-E208.
78. Terman A., Brunk U.T. Lipofuscin: mechanisms of formation and increase with age. APMIS 1998, 106:265-276.
79. Wang Z.M., Messi M.L., Delbono O. L-Type Ca(2+) channel charge movement and intracellular Ca(2+) in skeletal muscle fibers from aging mice. Biophys J 2000, 78:1947-1954.
80. Boffoli D., Scacco S.C., Vergari R., Solarino G., Santacroce G., Papa S. Decline with age of the respiratory chain activity in human skeletal muscle. Biochim Biophys Acta 1994, 1226:73-82.
81. Sweeney H.L., Bowman B.F., Stull J.T. Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. Am J Physiol 1993, 264:C1085-C1095.
82. Davis J.S., Satorius C.L., Epstein N.D. Kinetic effects of myosin regulatory light chain phosphorylation on skeletal muscle contraction. Biophys J 2002, 83:359-370.
83. Szczesna D., Zhao J., Jones M., Zhi G., Stull J., Potter J.D. Phosphorylation of the regulatory light chains of myosin affects Ca2+ sensitivity of skeletal muscle contraction. J Appl Physiol 2002, 92:1661-1670.
84. Godt R.E., Nosek T.M. Changes of intracellular milieu with fatigue or hypoxia depress contraction of skinned rabbit skeletal and cardiac muscle. J Physiol 1989, 412:155-180.
85. Short K.R., Bigelow M.L., Kahl J., Singh R., Coenen-Schimke J., Raghavakaimal S., et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci USA 2005, 102:5618-5623.
86. Doran P., Donoghue P., O'Connell K., Gannon J., Ohlendieck K. Proteomics of skeletal muscle aging. Proteomics 2009, 9:989-1003.
87. Capitanio D., Vasso M., Fania C., Moriggi M., Vigano A., Procacci P., et al. Comparative proteomic profile of rat sciatic nerve and gastrocnemius muscle tissues in ageing by 2-D DIGE. Proteomics 2009, 9:2004-2020.
88. Moriggi M., Vasso M., Fania C., Capitanio D., Bonifacio G., Salanova M., et al. Long term bed rest with and without vibration exercise countermeasures: effects on human muscle protein dysregulation. Proteomics 2010, 10:3756-3774.
89. Gong H., Hatch V., Ali L., Lehman W., Craig R., Tobacman L.S. Mini-thin filaments regulated by troponin-tropomyosin. Proc Natl Acad Sci USA 2005, 102:656-661.
90. Udaka J., Ohmori S., Terui T., Ohtsuki I., Ishiwata S., Kurihara S., et al. Disuse-induced preferential loss of the giant protein titin depresses muscle performance via abnormal sarcomeric organization. J Gen Physiol 2008, 131:33-41.
91. Hoshijima M. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol 2006, 290:H1313-H1325.
92. Isfort R.J., Wang F., Greis K.D., Sun Y., Keough T.W., Farrar R.P., et al. Proteomic analysis of rat soleus muscle undergoing hindlimb suspension-induced atrophy and reweighting hypertrophy. Proteomics 2002, 2:543-550.
93. Isfort R.J., Wang F., Greis K.D., Sun Y., Keough T.W., Bodine S.C., et al. Proteomic analysis of rat soleus and tibialis anterior muscle following immobilization. J Chromatogr B Analyt Technol Biomed Life Sci 2002, 769:323-332.
94. Seo Y., Lee K., Park K., Bae K., Choi I. A proteomic assessment of muscle contractile alterations during unloading and reloading. J Biochem 2006, 139:71-80.
95. Moriggi M., Cassano P., Vasso M., Capitanio D., Fania C., Musicco C., et al. A DIGE approach for the assessment of rat soleus muscle changes during unloading: effect of acetyl-L-carnitine supplementation. Proteomics 2008, 8:3588-3604.
96. Sorichter S., Puschendorf B., Mair J. Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury. Exerc Immunol Rev 1999, 5:5-21.
97. Sietsema K.E., Meng F., Yates N.A., Hendrickson R.C., Liaw A., Song Q., et al. Potential biomarkers of muscle injury after eccentric exercise. Biomarkers 2010, 15:249-258.
98. Meng F., Wiener M.C., Sachs J.R., Burns C., Verma P., Paweletz C.P., et al. Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry. J Am Soc Mass Spectrom 2007, 18:226-233.
99. Zhang H., Li X.J., Martin D.B., Aebersold R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol 2003, 21:660-666.
100. Zhang H., Yi E.C., Li X.J., Mallick P., Kelly-Spratt K.S., Masselon C.D., et al. High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol Cell Proteomics 2005, 4:144-155.
101. Alagaratnam S., Mertens B.J., Dalebout J.C., Deelder A.M., van Ommen G.J., den Dunnen J.T., et al. Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 2008, 8:1552-1563.
102. Doran P., Martin G., Dowling P., Jockusch H., Ohlendieck K. Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 2006, 6:4610-4621.
103. De Palma S., Morandi L., Mariani E., Begum S., Cerretelli P., Wait R., et al. Proteomic investigation of the molecular pathophysiology of dysferlinopathy. Proteomics 2006, 6:379-385.
104. Campanaro S., Romualdi C., Fanin M., Celegato B., Pacchioni B., Trevisan S., et al. Gene expression profiling in dysferlinopathies using a dedicated muscle microarray. Hum Mol Genet 2002, 11:3283-3298.
105. Liu J., Aoki M., Illa I., Wu C., Fardeau M., Angelini C., et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998, 20:31-36.
106. Tagawa K., Ogawa M., Kawabe K., Yamanaka G., Matsumura T., Goto K., et al. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients. J Neurol Sci 2003, 211:23-28.
107. Bansal D., Miyake K., Vogel S.S., Groh S., Chen C.C., Williamson R., et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003, 423:168-172.
108. Cenacchi G., Fanin M., De Giorgi L.B., Angelini C. Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J Clin Pathol 2005, 58:190-195.
109. Sjoblom B., Salmazo A., Djinovic-Carugo K. Alpha-actinin structure and regulation. Cell Mol Life Sci 2008, 65:2688-2701.
110. Ono S. Regulation of actin filament dynamics by actin depolymerizing factor/cofilin and actin-interacting protein 1: new blades for twisted filaments. Biochemistry 2003, 42:13363-13370.
111. Lemmers R.J., van der Vliet P.J., Klooster R., Sacconi S., Camano P., Dauwerse J.G., et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010, 329:1650-1653.
112. Saneyoshi T., Kume S., Amasaki Y., Mikoshiba K. The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos. Nature 2002, 417:295-299.
113. Hosoda T., Monzen K., Hiroi Y., Oka T., Takimoto E., Yazaki Y., et al. A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes. J Biol Chem 2001, 276:35978-35989.
114. Li J., Yin C., Okamoto H., Jaffe H., Oldfield E.H., Zhuang Z., et al. Proteomic analysis of inclusion body myositis. J Neuropathol Exp Neurol 2006, 65:826-833.
115. Banwell B.L., Engel A.G. AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 2000, 54:1033-1041.
116. Hutchinson D.O., Jongbloed B. Two-dimensional gel electrophoresis in inclusion body myositis. J Clin Neurosci 2008, 15:440-444.
117. Parker K.C., Kong S.W., Walsh R.J., Salajegheh M., Moghadaszadeh B., Amato A.A., et al. Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis. Muscle Nerve 2009, 39:739-753.
118. Parker K.C., Patterson D., Williamson B., Marchese J., Graber A., He F., et al. Depth of proteome issues: a yeast isotope-coded affinity tag reagent study. Mol Cell Proteomics 2004, 3:625-659.
119. Jin S., Daly D.S., Springer D.L., Miller J.H. The effects of shared peptides on protein quantitation in label-free proteomics by LC/MS/MS. J Proteome Res 2008, 7:164-169.
120. Huang Y., de Morree A., van Remoortere A., Bushby K., Frants R.R., Dunnen J.T., et al. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum Mol Genet 2008, 17:1855-1866.
121. Park J.H., Niermann K.J., Ryder N.M., Nelson A.E., Das A., Lawton A.R., et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum 2000, 43:2359-2367.
122. Rockerbie N.R., Woo T.Y., Callen J.P., Giustina T. Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol 1989, 20:629-632.
123. Salajegheh M., Kong S.W., Pinkus J.L., Walsh R.J., Liao A., Nazareno R., et al. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol 2010, 67:53-63.
124. Walsh R.J., Kong S.W., Yao Y., Jallal B., Kiener P.A., Pinkus J.L., et al. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 2007, 56:3784-3792.
125. Yuan W., Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 2001, 20:362-371.
126. Zhao C., Beaudenon S.L., Kelley M.L., Waddell M.B., Yuan W., Schulman B.A., et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc Natl Acad Sci USA 2004, 101:7578-7582.
127. Dastur A., Beaudenon S., Kelley M., Krug R.M., Huibregtse J.M. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J Biol Chem 2006, 281:4334-4338.
128. Malakhov M.P., Malakhova O.A., Kim K.I., Ritchie K.J., Zhang D.E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 2002, 277:9976-9981.
129. Desai S.D., Haas A.L., Wood L.M., Tsai Y.C., Pestka S., Rubin E.H., et al. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res 2006, 66:921-928.
130. Beck-Nielsen H. Mechanisms of insulin resistance in non-oxidative glucose metabolism: the role of glycogen synthase. J Basic Clin Physiol Pharmacol 1998, 9:255-279.
131. Eriksson J., Franssila-Kallunki A., Ekstrand A., Saloranta C., Widen E., Schalin C., et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989, 321:337-343.
132. Damsbo P., Vaag A., Hother-Nielsen O., Beck-Nielsen H. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991, 34:239-245.
133. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
134. Gebhart S.S., Shoffner J.M., Koontz D., Kaufman A., Wallace D. Insulin resistance associated with maternally inherited diabetes and deafness. Metabolism 1996, 45:526-531.
135. Wallace D.C. Mitochondrial diseases in man and mouse. Science 1999, 283:1482-1488.
136. Anderson C.M. Achieving breastfeeding success. Simple solutions to common concerns. Adv Nurse Pract 1999, 7:67-69.
137. Antonetti D.A., Reynet C., Kahn C.R. Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invest 1995, 95:1383-1388.
138. Winder W.W., Hardie D.G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 1999, 277:E1-E10.
139. Winder W.W., Holmes B.F., Rubink D.S., Jensen E.B., Chen M., Holloszy J.O. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 2000, 88:2219-2226.
140. Michael L.F., Wu Z., Cheatham R.B., Puigserver P., Adelmant G., Lehman J.J., et al. Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc Natl Acad Sci USA 2001, 98:3820-3825.
141. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
142. He J., Watkins S., Kelley D.E. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001, 50:817-823.
143. Hwang H., Bowen B.P., Lefort N., Flynn C.R., De Filippis E.A., Roberts C., et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 2010, 59:33-42.
144. Johnson D.T., Harris R.A., French S., Aponte A., Balaban R.S. Proteomic changes associated with diabetes in the BB-DP rat. Am J Physiol Endocrinol Metab 2009, 296:E422-E432.
145. Mullen E., Ohlendieck K. Proteomic profiling of non-obese type 2 diabetic skeletal muscle. Int J Mol Med 2010, 25:445-458.
146. Kitahara A., Toyota T., Kakizaki M., Goto Y. Activities of hepatic enzymes in spontaneous diabetes rats produced by selective breeding of normal Wistar rats. Tohoku J Exp Med 1978, 126:7-11.
147. Hahm J.R., Ahn J.S., Noh H.S., Baek S.M., Ha J.H., Jung T.S., et al. Comparative analysis of fat and muscle proteins in fenofibrate-fed type II diabetic OLETF rats: the fenofibrate-dependent expression of PEBP or C11orf59 protein. BMB Rep 2010, 43:337-343.